🩺What is Bronchiolitis?
The Pediatric Asthma Severity Score (PASS) is a clinical scoring system designed to assess acute asthma exacerbation severity in children. It evaluates five domains: respiratory rate (age-adjusted), oxygen saturation (SpO2), accessory muscle use, degree of dyspnea, and wheeze intensity. Each parameter is scored 0–3, yielding a total score of 0–12. The PASS provides objective severity classification to guide bronchodilator therapy, corticosteroid administration, and disposition decisions. It is widely used in pediatric emergency departments and aligns with BTS/SIGN and GINA asthma guidelines.
📊Clinical Assessment & Risk Scoring
Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Bronchiolitis:
Pediatric Asthma Severity Score
The Pediatric Asthma Severity Score (PASS) is a validated clinical tool for assessing the severity of acute asthma exacerbations in children. It uses five clinical parameters to objectively classify exacerbations as mild, moderate, or severe, guiding treatment decisions in the emergency setting.
Pediatric Pneumonia Severity Score
The Pediatric Pneumonia Severity Score (PPSS) is a clinical tool for assessing pneumonia severity in children under 5 years. It evaluates five clinical parameters — respiratory rate (age-adjusted), chest indrawing, oxygen saturation, ability to feed, and level of consciousness — to classify pneumonia as mild, moderate, or severe, guiding triage and management decisions.
🧬Diagnostic Logic & Scoring Breakdown
The PASS total score is the sum of five clinical parameters, each scored 0–3. The respiratory rate score is age-adjusted based on established pediatric norms. SpO2 reflects oxygen saturation on room air or current oxygen therapy. Accessory muscle use assesses supraclavicular, intercostal, and subcostal retractions. Dyspnea evaluates the child's ability to speak in full sentences, phrases, or single words. Wheeze intensity ranges from none to audible without a stethoscope. A total score of 0–3 indicates mild exacerbation, 4–7 moderate, and 8–12 severe. Optional PEF percentage predicted can be included for additional monitoring.
📢Clinical Significance & Implications
The Pediatric Asthma Severity Score is a clinically validated tool for objective assessment of acute asthma exacerbations in children. Asthma is the most common chronic disease in childhood, affecting approximately 6-7% of children worldwide, and acute exacerbations are a leading cause of pediatric emergency department visits and hospitalizations. The PASS addresses the need for a standardized, reproducible assessment that reduces inter-clinician variability and guides evidence-based treatment decisions. Early and accurate severity classification enables appropriate escalation of therapy — from outpatient bronchodilator therapy for mild exacerbations to intensive care interventions for severe disease. The score's five parameters capture the key domains of respiratory compromise: work of breathing (accessory muscles, respiratory rate), oxygenation (SpO2), ventilation (wheeze), and clinical impact (dyspnea/speech). Inclusion of age-adjusted respiratory rate scoring makes the tool applicable across the pediatric age spectrum. The optional PEF percentage adds objective lung function data when available. The PASS is aligned with BTS/SIGN and GINA guideline recommendations for acute asthma management in children.
💡 Clinical Assessment Scenario Example
A 6-year-old boy presents to the emergency department with acute wheezing and cough worsening over 12 hours. He has a history of asthma and was using his salbutamol inhaler at home without relief. On examination: respiratory rate is 40/min (moderate tachypnea for age, score 2), SpO2 is 93% on room air (score 1), there is moderate intercostal and subcostal retractions (score 2), he can only speak in phrases between breaths (score 1), and wheeze is audible throughout expiration with a stethoscope (score 2). Total PASS = 2 + 1 + 2 + 1 + 2 = 8/12. This falls in the Severe exacerbation range. PEF is 55% predicted. Immediate management includes high-flow oxygen to maintain SpO2 ≥94%, continuous nebulized salbutamol with ipratropium, IV methylprednisolone 1 mg/kg, and urgent PICU consultation.
💊Common Medications & Interventions
The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Bronchiolitis:
⚠️Clinical Assessment Pitfalls
❌ Mistake: Using adult respiratory rate thresholds for children
✅ Correction: Children have higher normal respiratory rates than adults, and thresholds vary significantly by age. Always use age-adjusted respiratory rate norms when scoring respiratory rate in PASS.
❌ Mistake: Relying solely on wheeze intensity without assessing other parameters
✅ Correction: A "silent chest" with barely audible wheeze may indicate severely reduced airflow and is scored 3, not low. Always assess all five PASS parameters together for accurate severity classification.
❌ Mistake: Using adult oxygen saturation thresholds for pediatric pneumonia assessment
✅ Correction: Children, especially under 5 years, have different oxygen saturation norms and physiology. SpO2 <90% in children is more concerning than in adults and warrants immediate intervention. Use pediatric-specific thresholds: ≥95% (normal), 90-94% (moderate concern), <90% (severe).
❌ Mistake: Interpreting chest indrawing in isolation without considering other PPSS parameters
✅ Correction: Chest indrawing alone does not determine severity. A child with mild intercostal retractions but normal SpO2, feeding, and consciousness may have mild pneumonia manageable as an outpatient. Always assess all five PPSS parameters together to determine the overall severity classification and appropriate disposition.
🚑When to Seek Medical Attention
This reference supports clinical assessment of Bronchiolitis; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.
❓Frequently Asked Questions
Q: What age range is the PASS validated for?
The Pediatric Asthma Severity Score is validated for children aged 1-18 years presenting with acute asthma exacerbations. For children under 1 year, alternative tools such as the Pediatric Respiratory Assessment Measure (PRAM) or Wood-Downes score are preferred, as the etiology of wheezing in infants may differ (e.g., bronchiolitis). For children over 18 years, standard adult asthma severity assessment tools are recommended.
Q: How often should PASS be reassessed during an exacerbation?
PASS should be reassessed after each bronchodilator treatment to monitor response. In moderate exacerbations, reassess every 20 minutes during the first hour of nebulized therapy. In severe exacerbations, continuous reassessment is needed. Documenting the trend in PASS scores provides objective evidence of improvement (declining score) or deterioration (rising score) to guide disposition decisions.
Q: What is the significance of "silent chest" in PASS?
A "silent chest" — where wheeze is barely audible or absent despite severe respiratory distress — is a concerning sign indicating severely reduced airflow and impending respiratory failure. In PASS, this is scored as 3 (most severe) for the wheeze parameter. It should not be misinterpreted as improvement. A silent chest requires immediate escalation of care, including PICU consultation and preparation for possible intubation.
Q: What age range is the PPSS validated for?
The Pediatric Pneumonia Severity Score is designed for children aged 2 months to 5 years presenting with signs of pneumonia. For infants under 2 months, alternative tools that account for different respiratory physiology and immune status are recommended. For children over 5 years, the modified PRESS (Pediatric Respiratory Illness Severity Score) or PORT/PSI scores may be more appropriate.
Q: How does the PPSS differ from the PRESS score?
While the PPSS is a modified adaptation of the Pediatric Respiratory Illness Severity Score (PRESS), it has been specifically tailored for pneumonia assessment in younger children (under 5 years). The PPSS simplifies the scoring to a 0-2 scale per component (vs broader ranges in PRESS), incorporates WHO IMCI danger signs (feeding ability, consciousness), and excludes parameters more relevant to asthma/bronchiolitis (such as wheeze). The PPSS also provides explicit disposition recommendations (outpatient, inpatient ward, ICU) aligned with WHO pneumonia management guidelines.
Q: Can the PPSS be used in community health settings without X-ray or labs?
Yes. The PPSS is designed for use in settings with limited diagnostic resources, including primary care clinics and community health centers. All five parameters are assessed clinically without requiring chest X-ray, blood tests, or advanced equipment: respiratory rate is counted manually, chest indrawing is observed, SpO2 can be measured with a portable pulse oximeter (or clinical cyanosis assessment if unavailable), feeding ability is reported by the caregiver, and consciousness is assessed by the clinician. This makes the PPSS particularly valuable in resource-limited settings where pneumonia burden is highest.
📚Evidence-Based References
Medically Reviewed By
Dr. Mahmoud El-Sayed
MD, MSc | Pediatrics
Dr. Mahmoud is a pediatric consultant with over 12 years of clinical experience in pediatric emergency medicine and respiratory disorders in children.